Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Owen Witte
AddedFeb 15, 2024
UpdatedMay 31, 2026
Owen Witte

Owen Witte

Board Member, Allogene Therapeutics

CrunchbaseThe Org

Owen Witte's Career

Allogene Therapeutics
Allogene Therapeutics

South San Francisco, CA, US

Board Member· Board
Trethera
Trethera

Santa Monica, CA, US

Co-Founder
Sofie
Sofie

Dulles, VA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Owen Witte's Career

Allogene Therapeutics
Allogene Therapeutics
Public$781.8M3612017South San Francisco, CA, US
Board Member· Board

Leadership at Allogene Therapeutics

David ChangDavid ChangFounder
Liz BarrettLiz BarrettBoard Member
Stephen L. MayoStephen L. MayoBoard Member
Debbie MessemerDebbie MessemerBoard Member
John DeYoungJohn DeYoungBoard Member
Franz HumerFranz HumerBoard Member
Trethera
Trethera
Angel$17.4M302015Santa Monica, CA, US
Co-Founder

Leadership at Trethera

Michael JungMichael JungCo-Founder
Caius RaduCaius RaduCo-Founder
Kenneth SchultzKenneth SchultzBoard Member
David NathansonDavid NathansonCo-Founder
Louis GondaLouis GondaBoard Member

Similar to Trethera

Dual TherapeuticsDual TherapeuticsCleveland, OH, USCancer Therapeuticsest. 2012Dual TherapeuticsCleveland, OH, US · est. 2012

Dual Therapeutics: Small-molecule modulator producer for comprehensive cancer treatment.

Series A · $6.6M7
Palm TherapeuticsPalm TherapeuticsSan Diego, CA, USCancer Treatmentest. 2018Palm TherapeuticsSan Diego, CA, US · est. 2018

Revolutionizing cancer treatment with next-gen root-level therapeutics.

Angel · $991.1k7
Soteria BiotherapeuticsSoteria BiotherapeuticsSan Francisco, CA, USCancer Therapiesest. 2018Soteria BiotherapeuticsSan Francisco, CA, US · est. 2018

Soteria: A biotech firm innovating safer, more effective cancer treatments via its T-LITE™ platform.

Series A · $42M11
Nirogy TherapeuticsNirogy TherapeuticsNatick, MA, USDrug Developmentest. 2013Nirogy TherapeuticsNatick, MA, US · est. 2013

Nirogy Therapeutics: Innovating small molecule drugs to target cellular transporters and disrupt tumor growth.

Series A · $18.5M16
Sofie
Sofie
Acquired$44.6M02008Dulles, VA, US
Co-Founder

Leadership at Sofie

Johannes CzerninJohannes CzerninCo-Founder
K. Leonard JudsonK. Leonard JudsonBoard Member
Michael PhelpsMichael PhelpsBoard Member
Pat PhelpsPat PhelpsBoard Member

Similar to Sofie

Sova PharmaceuticalsSova PharmaceuticalsLos Angeles, CA, USDrugs, Pharmaceuticalsest. 2010Sova PharmaceuticalsLos Angeles, CA, US · est. 2010

Sova Pharmaceuticals, Inc.: US-based manufacturer of human and veterinary pharmaceutical preparations.

Public · $4M10
Vertice PharmaVertice PharmaNew Providence, NJ, USHealth, Pharmaceuticalsest. 2015Vertice PharmaNew Providence, NJ, US · est. 2015

Vertice Pharma: A UK-based specialty pharmaceuticals company, developing and distributing quality, affordable health solutions.

Private Equity · $300M175
Kalyra PharmaceuticalsKalyra PharmaceuticalsEscondido, CA, USDrug Distributionest. 2012Kalyra PharmaceuticalsEscondido, CA, US · est. 2012

US-based Kalyra Pharmaceuticals, founded in 2012, specializes in wholesale distribution of various drugs.

Series A · $6.2M30
A&G PharmaceuticalA&G PharmaceuticalColumbia, MD, USDrugs, Pharmaceuticalsest. 2000A&G PharmaceuticalColumbia, MD, US · est. 2000

A&G Pharmaceutical, Inc: A US-based company, wholesaling prescription and proprietary drugs since 2000.

Angel · $2.1M31

Owen Witte's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Owen Witte

David AgusDavid AgusBoard Member · Thrive GlobalCharles SawyersCharles SawyersBoard Member · NovartisIan ButterworthIan ButterworthCo-Founder · LeukoSanjiv GambhirSanjiv GambhirCo-Founder · EarliLouis AronneLouis AronneCo-Founder · IntellihealthSteven QuaySteven QuayBoard Member · Atossa Therapeutics